Dimensional Fund Advisors’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
VCIM
VCM
SCM
ACA
IHAM
ACM
Dimensional Fund Advisors's TARA Position: Q1 2026 in Review
Dimensional Fund Advisors increased its Protara Therapeutics (TARA) stake by 134% in Q1 2026, buying an estimated $1.8M and bringing the position to 531,267 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2637.
Dimensional Fund Advisors first reported a position in TARA in Q3 2017 and has held it in 19 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.
- Dimensional Fund Advisors held 531,267 shares of Protara Therapeutics worth $2.77M as of Q1 2026.
- Dimensional Fund Advisors bought 304,110 Protara Therapeutics shares in Q1 2026, an estimated $1.8M.
- Protara Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2637 holding.
- Dimensional Fund Advisors first reported a position in Protara Therapeutics in Q3 2017 and has held it in 19 quarters since.
- 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.